Microarrays & Multiplexing

News on microarrays, multiplexing, genotyping, cytogenetics, gene expression profiling in genetics, genomics, and molecular diagnostics.

AusDiagnostics Gets CE Mark for Multiplex Coronavirus, Flu, RSV Assay

The company said the test achieved 100 sensitivity and 100 percent specificity in a study of 210 samples that included 44 from COVID-19 patients.

Chan Zuckerberg Initiative, UCSF, Stanford Partner to Boost Bay Area Coronavirus Testing

The partners' "COVID-19 task force" will invest in ePlex molecular testing platforms from GenMark Diagnostics to quadruple UCSF's testing capacity.

Genomica Coronavirus Dx Kits Garner CE Mark

Genomica, a PharmaMar Group company, has developed kits based on real-time PCR and its CLART low-density microarray technology.

NanoString Technologies Q4 Revenues Up 23 Percent

The firm said it took in $33.6 million in product and service revenue in the quarter, a 42 percent increase from $23.6 million in Q4 2018.

Quotient Limited Receives CE Mark for Serological Disease Screening Microarray

The microarray runs on the company's CE marked Mosaiq system for blood grouping and transfusion-transmitted infection screening.

Feb 04, 2020

CARB-X Awards Pattern Bioscience up to $21.9M for Rapid ID/AST System

Jan 30, 2020

Quotient Limited Fiscal Q3 Revenues Up 18 Percent

Dec 20, 2019

Prostate Cancer Modeling Study Supports Precision Screening Approach

Dec 18, 2019

UCLA Team Develops Point-of-Care Assay for Early-Stage Lyme Disease

Dec 11, 2019

Array Genomics Sets Out to Build Business for Bladder Cancer Test

Premium

Dec 06, 2019

Local Coverage Determinations Roundup: Transplant Genomics, Opko Health

Dec 03, 2019

Veracyte Exclusively Licenses NanoString Diagnostic Platform for Up to $60M

Nov 26, 2019

NanoString-Based Genotype, Phenotype Test Rapidly Detects Antimicrobial Resistance

Premium

Nov 07, 2019

Quotient Prices $78.4M Public Offering of Shares

Nov 06, 2019

Quanterix Q3 Revenues Increase 41 Percent

Nov 04, 2019

Quotient Limited Fiscal Q2 Revenues Rise 26 Percent

Nov 01, 2019

Local Coverage Determinations Roundup: Transplant Genomics

Oct 29, 2019

Mobidiag Inks Distribution Agreements in Europe, Middle East for Dx Products

Sep 06, 2019

Specific Diagnostics Secures $12.5M in Funding

Aug 28, 2019

SQI Diagnostics Q2 Revenues Tick Up Sharply

Aug 05, 2019

Quotient Fiscal Q1 Revenues Grow 4 Percent

Aug 01, 2019

MBio Awarded $1M NIH Grant to Develop Point-of-Care Sepsis Assay

Jul 17, 2019

PathogenDx, Nationwide Laboratory Services Partner on Fungal Testing

Jul 11, 2019

Cancer Detection Firm StageZero Raises C$2.7M

Jul 02, 2019

Menu